Current disease status-First occurrence of the cancer - Page 36 of 59 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Posted by on May 14, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to evaluate if the outcomes of surgery following chemotherapy are different based on the focality of breast cancer tumors.  Some background Breast cancer can be characterised as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found...

Read More

‘Stops and starts’ – an acceptable method of administering hormone therapy in prostate cancer?

‘Stops and starts’ –  an acceptable method of administering hormone therapy in prostate cancer?

Posted by on May 13, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effect of degarelix in treating prostate cancer.  Some background Hormone therapy is a prostate cancer treatment that targets the male sex hormones active in prostate cancer, such as testosterone. Degarelix (Firmagon) is a drug used in hormone therapy that reduces the levels of testosterone to...

Read More

Lung invasion: what are the outcomes of colorectal cancer patients who have undergone lung surgery?

Posted by on May 11, 2015 in Colorectal cancer | 0 comments

In a nutshell This study examined cancer relapse rates and treatment options for patients with colorectal lung metastases (colorectal cancer that has spread to the lungs) after curative lung surgery. Some background Roughly 20% of patients with colorectal cancer will have cancer in a distant organ by the time they are diagnosed. The cancer will...

Read More

Is age related to treatment side-effects experienced in prostate cancer patients?

Is age related to treatment side-effects experienced in prostate cancer patients?

Posted by on May 5, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether age had an effect on patient quality of life after localized prostate cancer treatment. Some background Localized prostate cancer is cancer that is confined within the prostate gland. Treatment for localized prostate cancer can cause undesirable effects in patients, affecting their quality...

Read More

Who says age matters? Bevacizumab (Avastin) is safe and effective for treating colorectal cancer in patients old and young

Who says age matters? Bevacizumab (Avastin) is safe and effective for treating colorectal cancer in patients old and young

Posted by on May 4, 2015 in Colorectal cancer | 0 comments

In a nutshell This study examined the safety and efficacy of bevacizumab (Avastin) for treating elderly patients with metastatic colorectal cancer (cancer that has spread from the colon or rectum to distant sites). Some background Bevacizumab is an anti-cancer drug that blocks the formation of new blood vessels needed for the cancer to grow and...

Read More

Is capecitabine better with lapatinib or trastuzumab for HER2 positive metastatic breast cancer?

Is capecitabine better with lapatinib or trastuzumab for HER2 positive metastatic breast cancer?

Posted by on Apr 28, 2015 in Breast cancer | 0 comments

In a nutshell This paper studied the effect of lapatinib (Tyverb) plus capecitabine (Xeloda) versus trastuzumab (Herceptin) plus capecitabine in patients with human epidermal growth factor receptor 2 (HER2) positive breast cancer that has spread to other parts of the body. Some background Trastuzumab is used  to treat HER2 positive breast...

Read More

Comparing urinary incontinence and erectile dysfunction as side effects after robotic vs. open prostate removal

Comparing urinary incontinence and erectile dysfunction as side effects after robotic vs. open prostate removal

Posted by on Apr 28, 2015 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the complications associated with robotic-assisted prostate removal (minimally invasive) compared to an open surgical procedure (more invasive).   Some background Open surgical removal of the prostate has previously been the traditional surgical approach for prostate cancer treatment. Robot-assisted...

Read More

Calling on patients with colorectal cancer that has spread to the liver to test a drug treatment option

Calling on patients with colorectal cancer that has spread to the liver to test a drug treatment option

Posted by on Apr 24, 2015 in Colorectal cancer | 0 comments

In a nutshell This study is being carried out in New York and New Jersey. It will examine whether adding panitumumab (Vectibix) to chemotherapy reduces the risk of the cancer returning in colorectal cancer patients with liver metastases (cancer that has spread to the liver). The authors will also record any adverse events experienced and patient...

Read More